Background/Aims: A significant rise of blood pressure in response to a given salt load is a weak indication of high salt sensitivity, supposed to foster the development of arterial hypertension and related diseases in later life. In search of an alternative method we recently developed the salt blood test (SBT), a new concept for quantifying salt sensitivity (SS). Based on this concept, namely that red blood cells (RBC) report on salt sensitivity, the SBT-mini was developed. Methods: The SBT-mini utilizes a droplet of capillary blood mixed with a 'smart' Na + cocktail. Red blood cells (RBC) of this mixture are allowed to sediment by gravity in a glass tube. SS is quantified by measuring RBC sedimentation rate. 90 healthy volunteers (39 males, 51 females; mean age: 23±0.5 years) were evaluated and 'standard values' for males and females were derived. Results: Sodium buffer capacity of female blood is about 20 % smaller as compared to male blood due to the lower hematocrit of females. SS of an individual is related to the mean standard value (set to 100 %) of the respective male/female cohort. High SS (> 120 %) has been found in 31 % of males and 28 % of females. Conclusions: SS can be estimated derived from the individual RBC sodium buffer capacity as measured by the SBT-mini. About one third of a healthy test cohort exhibits a high sensitivity to salt. Reduction of sodium consumption to at least two grams per day (equals five grams of NaCl per day as suggested by the WHO) is recommended, particularly for individuals with high salt sensitivity.
Introduction
Salt sensitivity (SS) characterizes the ability of the individual organism to control body sodium. Daily intake of large amounts of salt (NaCl), very common in most societies worldwide, is known to foster the development of arterial hypertension damaging brain, heart, kidney and the blood vessel system [1] [2] [3] [4] [5] [6] [7] [8] . Although it would be very useful being able to quantify SS, practicable methods are barely at hand. Accurate testing of SS is usually laborious and associated with low patient compliance [9] [10] [11] . Recently, the so-called salt blood test (SBT) was developed [12, 13] . It describes salt sensitivity of erythrocytes in quantitative terms and, indirectly, allows insight into the functional properties of the inner surface layer of blood vessels. We found a positive correlation between erythrocyte salt sensitivity and blood pressure though we do not know yet whether this relationship is coincidental or causative [14] . The test is based on a blood sample taken from venous puncture. Red blood cells (RBC) must be isolated, washed and suspended in two different Na + cocktails before measurements can be performed. Although this procedure is already rather simple, it needs several milliliters of venous blood, some washing procedures and the use of a centrifuge. Therefore, this SBT needs some basic laboratory expertise and equipment which is not accessible everywhere. Since a test for SS should be as simple as possible so that everybody should be able to perform it, independent of laboratory skills, we modified (i.e. simplified) the original SBT. The emphasis was on "fewer steps" and "smaller blood samples". We finally arrived at a new design, the SBT-mini. This test needs only 50 µl of capillary blood, requires no centrifugation of the sample and, for comparison, uses standard values for males and females obtained from healthy individuals. Nevertheless, the SBT-mini reports on SS in quantitative terms, with a technical scatter in the range of 5%. Figure 1 shows the performance of the SBT-mini. (A) shows the five components of the test (from left to right: safety lancet, Sarstedt, Nümbrecht, Germany; Minivette © POCT, Tri-K-EDTA, Sarstedt; PCR soft tube, 0.2ml, Biozym Scientific GmbH, filled with 50 µl of Na + cocktail, CARE diagnostica Laborreagenzien GmbH, Voerde, Germany; hematocrit tube Safecap P75-2000M, Scholz GmbH, Neubiberg, Germany; plexiglass home-built tube holder. (B) Filling of the Minivette © by capillary forces. Blood enters and stops automatically when filled (50 µl). (C) Blood is delivered into the Na + cocktail and mixed well by hand for about 20 seconds. (E) The blood/Na + cocktail mixture is allowed to enter the hematocrit tube by the use of capillary/gravity forces. (F) The hematocrit tube is vertically mounted in the tube holder and the length of the RBC-free supernatant (S x ) is measured after 60 minutes. (G) SS is calculated as follows: SS (%) = (S x / standard) · 100 S x and standard are given in millimeters. The standard value for males is 21.4 mm (60 min value) and the one for females is 26.1 mm (60 min value). The two standard values serve as reference values derived from 39 male and 51 female healthy volunteers, respectively. Mean SS obtained from each of these two cohorts is set to 100% indicating average SS in a normal population.
Materials and Methods

Salt Blood Test (SBT-mini)
In addition, hematocrit values were obtained for each individual by centrifugation of the same sample as used for the SS measurements. Hematocrit is given as the erythrocyte volume percentage (%) of whole blood. A video that describes the concept and the step-by-step procedure of the test can be found at: https:// www.youtube.com/watch?v=afqIGhJhqig.
Statistics
Data are expressed as mean ± SEM or SD as appropriate. Significance was tested with the unpaired student's t test. Non-parametric data were tested for significance with the Mann-Whitney-U-test. Data were termed "significantly different" when the probability of error was smaller than 5% (p < 0.05). Figure 2 shows the lengths of the supernatants measured at different ambient Na + concentrations over time. Please note that the length of the supernatant that develops over a giv- en time period at a specific Na + concentration is positively correlated to the individual's SS. The different (ambient) Na + concentrations (in mM: 111, 117, 124, 131 and 137) were created by mixing 50 µl of whole blood (taken from the Minivette © ) with 50 µl of five different Na + cocktails. As expected the speed of supernatant formation (i.e. the sedimentation velocity) strong- ly depends on the respective Na + concentrations. This confirms previous studies [12, 15, 16] . It is not due to different osmolalities since even balanced osmolalities (by adding adequate amounts of sucrose) does not influence the results (data not shown). The reason why we chose the time point "60 minutes" for the SBT-mini was as follows: (i) The separation between supernatant and erythrocyte sediment was (optically) sharp enough to allow a precise measurement of supernatant length (see figure 1 F). (ii) The curve was well embedded between the minimal (about 10 mm) and maximal (about 40 mm) values of supernatant lengths that can be expected in samples from different (low and high salt sensitive) individuals. Figure  3 shows a graph in which the dependence of the length of the supernatant on the individual hematocrit values is displayed. It shows some dependence of SS mainly when hematocrit values are above 40%. Such hematocrit values are typical (physiological) for the male cohort (green symbols). This is plausible because the RBC concentration influences the erythrocyte Na + buffering capacity of the individual sample. Therefore, we used two separate standard values, one for males and another one for females. Figure 4 shows the frequency distributions of supernatant lengths obtained in 90 healthy individuals (39 males, 51 females, mean age = 23±0.5 years). The curve of the female participants is clearly located at the right side of the figure in comparison to the curve of male cohort. This is mainly due to the lower hematocrit of females. When this is taken into account and the data "corrected" for the unequal hematocrit values, then this sex difference vanishes, i.e. the curve of the female cohort shifts to the left as expected (figure 4). The histograms of the male and the female cohort exhibit two peaks, irrespective of the hematocrit and more pronounced in women, indicating that two subpopulations may exist, namely a low and a high salt sensitive one. Figures 5 and 6 show the individual SS values for the male and the female cohort. SS was calculated as mentioned above. The SS value of 100 % is based on the mean SS value obtained for each cohort. Values between 80 and 120 % were termed "average SS values" in order to indicate that values may considerably scatter. Low SS (< 80 %) is found in 28 % (males) and 31 % (females). Average SS (80 to 120 %) is found in 41 % (males and females) and high SS (> 120 %) is found in 31 % (males) and 28 % (females). Reliability of the SBT-mini is documented in table 1. Performing 15 tests in parallel (at the same time) using capillary blood of a single person exhibits a stan- compared to the corresponding values of the original SBT. This difference is negligibly small at high salt sensitivity but appears to increase at very low salt sensitivity. Since the focus is on the detection of high salt sensitivity, this difference should not really matter.
Results
Discussion
Salt sensitivity of humans is poorly defined. A highly salt (i.e. sodium) sensitive person is likely to respond to salt overload with an increase of arterial blood pressure [7, 17, 18] . It is still unclear what kind of mechanism may be behind the differences in salt sensitivity. Most likely, the kidneys play a major role [19] . The capability of renal sodium excretion determines how long Na + , entering the body after a salty meal, remains in the organism. Since daily salt intake large deviation reflects mainly the wide spectrum of SS as shown in figures 5 and 6. Finally, we directly compared data (six individuals) obtained with the original SBT [12, 13] and the SBT-mini (figure 7). We found a good correlation between the two tests (correlation coefficient r 2 = 0.89). Nevertheless, the SBTmini indicates an apparently higher salt sensitivity (in average about +6%) as Table 1 . Technical and biological scatters of the SBT-mini attracted by negatively charged glycocalyx surfaces as endothelium and RBC [16, 26] . Due to its large charge density and its thick water shell, Na + determines the net charge of the glycocalyx. These typical features of this actually 'mousy' ion explain the big impact of Na + on net surface charges, known to influence the zeta potential [15, 27] .
Previously, we observed that the erythrocyte glycocalyx 'mirrors' the glycocalyx of the vascular endothelium [13] . Both erythrocyte and endothelial glycocalyces selectively bind Na + [16, 26] . Thus, any increase in extracellular Na + (plasma Na + concentration) neutralizes some of the remaining (yet free) negative charges on the erythrocyte/endothelial surface. This will influence the zeta potential. Based on this concept, the so-called salt blood test (SBT) was developed three years ago [12] . Applying the SBT to healthy volunteers, two subgroups could be identified, a low and a high salt sensitive group. In the meantime, two clinical studies were performed. One study showed that patients with manifest hypertension are more frequently found in the highly salt sensitive subgroup [14] . Another study, carried out with the blood of dialysis patients, showed that the RBC glycocalyx is improved after acute hemodialysis, i.e. salt sensitivity decreases or, in other words, the Na + buffering power of the glycocalyx recovers by a 4-hour hemodialysis of patients suffering from chronic kidney disease [28] .
Aiming to reach not only patients under professional medical care but also to address healthy people without specific medical education we set out trying to make the SBT easier to use. The SBT-mini as described here is the result of these efforts. In comparison to the original SBT the SBT-mini has advantages and disadvantages. The advantages are as follows: (i) Minimal equipment and only a few steps are sufficient to quantify salt sensitivity. (ii) Only 50 µl of capillary blood is enough to perform the test. A potential disadvantage of the SBT-mini is the fact that the individual hematocrit influences the result. This is only critical when larger hematocrit fluctuations are to be expected, e.g. in anemic/hyperemic patients. Even under these conditions, the SBT-mini can still be performed but one has to be aware that the result of such a measurement includes both, RBC quantity (hematocrit) and the RBC quality (Na + buffer capacity). If these two variables ought to be separated, then the hematocrit must be measured. The significant difference in hematocrit between males and in virtually all societies worldwide is usually (too) high (between 2 and 6 grams of Na + ), even healthy kidneys reach the limits of their Na + excretion capacity. As a consequence, large quantities of Na + will be transiently deposited in skin [20] . Na + stores will grow with time finally damaging the organism [21, 22] . Na + , a small kosmotropic ion with a rather high charge density, is a so-called "water structure maker" (i.e. binds water avidly) [23] [24] [25] . Due to the large charge density of Na + , this ion species is preferentially females was considered when the SBT-mini was developed. We offer two standard values, one for females and one for males. Using these two standards the influence of sex differences in the hematocrit is minimized.
The results of the original SBT compare well with the data obtained with the SBT-mini. When the hematocrit differences between males and females is taken into account we do not find a significant sex difference in SS. This agrees with the results of the original SBT [12] . Furthermore, the original SBT showed that 28 % of the (male/female) study participants (61 healthy young persons, mean age 23 years) were highly salt sensitive (SS > 20 % of average value). This matches very well with the data of the present study performed on a comparable cohort (90 healthy young people, mean age 23 years) where 31 % of the male cohort and 28 % of the female cohort were found highly salt sensitive.
In comparison to the original SBT published previously the SBT-mini does not need any centrifugation and RBC washing procedures but uses a mixture of whole capillary blood with one single 'smart' Na + cocktail. It contains a low Na + concentration that, on the one hand, is high enough to prevent any hemolysis (osmolarity: about 200 mOsmol/l) and, on the other hand, is low enough to maintain a sufficient moiety of free negative RBC surface charges. RBC sedimentation rate depends crucially on this well-defined balance between Na + and the (still unshielded) free negative charges. We tested many different Na + concentrations (some curves are shown in figure 2 ) and finally chose the most suitable one. 'Most suitable' means that the sedimentation rate (indirectly representing the zeta potential) measured after 60 minutes is well readable from the test tube so that even extreme values (i.e. extremely low and high salt sensitive donor blood) can be measured. In contrast to the original SBT in which Ca 2+ was removed by the washing procedures we used EDTA to chelate Ca
2+
. This is necessary because Ca 2+ is known to strongly interfere with charged surfaces and thus would mask the Na + associated changes of the zeta potential [26] . Finally, we modified the dextrane concentration. Dextrane is necessary to render RBC surfaces 'sticky' facilitating RBC aggregation. As described previously, dextrane sticks to the very surface of RBC [15, 27] . The right molecular size is quite critical since the dextrane molecules will 'hide' in the glycocalyx and RBC aggregate when RBC surfaces come (physically) close to each other (few nanometers). The distance depends upon the 'quality' of the glycocalyx. A poor glycocalyx has a reduced number of electrical charges and thus RBC aggregate more easily. Dextrane facilitates this tendency for aggregation and makes this phenomenon measurable (sedimentation rate).
Similar as already shown with using the original SBT, the SBT-mini discloses a doublepeak histogram in the healthy population indicating that there may exist two subgroups, a low salt sensitive and a high salt sensitive group. It seems to be more pronounced in women as in men. SS values in the range of 80 to 120 % were termed 'average SS' indicating that this is about the range (about 3 times the standard error) expected for healthy persons (including all types of SS). The double-peak histograms cannot simply be explained by genetic predisposition [29] but can be also due to distinct differences in life style of the individuals [30] . For example, application of polyphenolic compounds in vitro [12] and in vivo [16] can influence SS. Also elevated concentrations of plasma sodium can gradually destroy the charged surface layers of endothelium and RBC as recently demonstrated [8, 31, 32] . Furthermore, SS changes in inflammatory diseases/atherothrombotic processes are likely to occur since endothelial surface layers are known to lose their negative charges under such conditions [33] [34] [35] . It can be concluded that any changes in Na + buffer capacity of the RBC glycocalyx will be reported by the SBT-mini. This may happen in many different diseases such as cancer, immune and infectious diseases. Nevertheless, such changes do indicate an altered SS of these individuals.
The concept of the SBT-mini is clearly different in comparison to the classical measurement of erythrocyte sedimentation rate (ESR). RBC sedimentation as measured by the SBT-mini depends mainly on the Na + -specific properties of the RBC surface layer (blood is diluted by Na + cocktail, Ca 2+ has been chelated by EDTA and K + is known for its negligible interference with the RBC glycocalyx [16] ) while ESR performed in whole blood depends mainly on the functional characteristics of plasma proteins and their inference with RBC.
Conclusion
The SBT-mini could be suitable for evaluating salt sensitivity in humans. With a technical error of 5 %, easy handling and good reliability the SBT-mini should promise wide-spread use. Since SS is not a genetically-fixed but a rather variable value, the test could be useful for evaluating the individual's response to any preventive actions (e.g. low-salt diet, life style changes) and/or to drug treatment in cardiovascular diseases.
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